17 results
20-F
2021 FY
IINN
Inspira Technologies Oxy B.H.N. Ltd
31 Mar 22
Annual report (foreign)
4:48pm
is primarily attributed to acute respiratory failure (69%) and chronic lung disease (10%). In a 2017 report in the Forum of International Respiratory Societies … with respiratory failure and acute exacerbation of chronic lung disease). The cost estimate is based on high volume, mass production of the disposable respiratory
6-K
EX-99.1
IINN
Inspira Technologies Oxy B.H.N. Ltd
1 Feb 22
Report of Foreign Private Issuer
8:58am
market for the company is expected to grow steadily in the coming years due to the increasing prevalence of chronic disorders, growing geriatric … Center. Lecturer at the Hebrew University Faculty of Medicine & Hadassah Medical School. Current research: Chronic Obstructive Pulmonary Diseases
POS AM
IINN
Inspira Technologies Oxy B.H.N. Ltd
27 Oct 21
Prospectus update (post-effective amendment)
9:17am
induced coma and intubation, which is primarily attributed to acute respiratory failure (69%) and chronic lung disease (10%). According to July 2020
6-K
EX-99.1
1d8iw 4ot1cssluv
12 Oct 21
Report of Foreign Private Issuer
4:01pm
424B4
8rh5 njyi
15 Jul 21
Prospectus supplement with pricing info
4:06pm
F-1/A
6rb7w 777o
1 Jul 21
Registration statement (foreign) (amended)
11:58am
FWP
2j0nxce islo2sofr
28 Jun 21
Free writing prospectus
11:45am
F-1/A
tsgaa76kp
28 Jun 21
Registration statement (foreign) (amended)
11:41am
FWP
3az 9hlq06ztx
9 Jun 21
Free writing prospectus
6:17am
F-1/A
e2bmlg pdu2
8 Jun 21
Registration statement (foreign) (amended)
5:26pm
F-1/A
5f2nmcnmrk 0r
29 Mar 21
Registration statement (foreign) (amended)
5:19pm
F-1/A
8qt3ynsjr8xpgx9778
22 Mar 21
Registration statement (foreign) (amended)
11:24am
F-1
8sthe
5 Mar 21
Registration statement (foreign)
3:03pm
DRS/A
emkvr f5z
17 Feb 21
Draft registration statement (amended)
12:00am
DRS
h993u6uif0cwva9 k5o
29 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next